Member access

4-Traders Homepage  >  Shares  >  SHANGHAI STOCK EXCHANGE  >  Jiangzhong Pharmaceutical Co Ltd    600750   CNE000000M80

End-of-day quote. End-of-day quote SHANGHAI STOCK EXCHANGE - 03/27
30.09 CNY   +0.40%
 SummaryQuotesChartsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shanghai Stock Exchange
03/23/2015 03/24/2015 03/25/2015 03/26/2015 03/27/2015 Date
30.96(c) 30.19(c) 29.94(c) 29.97(c) 30.09 Last
7 959 219 7 120 486 4 752 381 5 169 795 4 381 918 Volume
+5.06% -2.49% -0.83% +0.10% +0.40% Change
More quotes
Financials ( CNY)
Sales 2014 3 364 M
EBIT 2014 270 M
Net income 2014 229 M
Finance 2014 424 M
Yield 2014 1,14%
Sales 2015 3 435 M
EBIT 2015 344 M
Net income 2015 299 M
Finance 2015 500 M
Yield 2015 1,32%
PER 2014 39,64
PER 2015 31,07
EV / Sales 2014 2,55x
EV / Sales 2015 2,47x
Capitalization 8 997 M
More Financials
Company
Jiangzhong Pharmaceutical Co. Ltd. is engaged in the manufacture and sale of pharmaceutical products.Main products consist of Chinese, water-soluble and botanical medicines; penicillin injection and raw materials; capsules; antibiotics and others.Other activities include wholesale and retail of... 
Sector
Pharmaceuticals
Calendar
-
More about the company
Surperformance© ratings of Jiangzhong Pharmaceutical
Trading Rating : Investor Rating :
More Ratings
Latest news on JIANGZHONG PHARMACEUTICAL

- No features available -

More news
Sector news : Pharmaceuticals - NEC
04:02a UCB : Convening notice to attend the general meeting of shareholders
02:35a SHIRE : *repeat: ubs raises shire price target to 6600 pence - 'buy'
02:32a OTSUKA : Announces Change in Status of Representative Director (125KB)
More sector news : Pharmaceuticals - NEC


Comments 
Advertisement
Chart JIANGZHONG PHARMACEUTICAL
Duration : Period :
Jiangzhong Pharmaceutical  Technical Analysis Chart | 600750 | CNE000000M80 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF